Engine Capital Management, LP - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 152 filers reported holding PDL BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Engine Capital Management, LP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2020$7,790,000
-29.0%
2,676,850
-15.3%
5.12%
-10.3%
Q1 2020$10,969,000
-45.5%
3,161,163
-49.0%
5.71%
-27.2%
Q4 2019$20,114,000–6,198,430–7.84%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders